• No se han encontrado resultados

Revisión de la evidencia de talidomida y lenalidomida en diferentes enfermedades hematológicas: leucemia linfocítica crónica, amiloidosis primaria, mielofibrosis y síndrome mielodisplásico

N/A
N/A
Protected

Academic year: 2020

Share "Revisión de la evidencia de talidomida y lenalidomida en diferentes enfermedades hematológicas: leucemia linfocítica crónica, amiloidosis primaria, mielofibrosis y síndrome mielodisplásico"

Copied!
13
0
0

Texto completo

Loading

Referencias

Documento similar

Abstract: Transepidermal water-loss (TEWL), stratum-corneum hydration (SCH), erythema, elas- ticity, pH and melanin, are parameters of the epidermal barrier function and

In this context, we conducted a study on the use, effectiveness, and safety of OAC prescribed for stroke prevention in NVAF from 2011–2020 in a Primary Health Care (PHC) cohort

Association between a 10% increment in the consumption of ultra-processed food and drink and chronic lymphocytic leukemia in the MCC-Spain study, further adjusted for nutritional

The main goal of this work is to extend the Hamilton-Jacobi theory to different geometric frameworks (reduction, Poisson, almost-Poisson, presymplectic...) and obtain new ways,

The paper is structured as follows: In the next section, we briefly characterize the production technology and present the definition of the ML index as the geometric mean of

Over the next 5 years, hematologic management of hemophilic patients with inhibitors should improve as a result of common use of enhanced on-demand treat- ment of

145 We will next review the available evidence demonstrating the presence of neuroinflammation and its potential relationship with P2X7Rs, from preclinical in vitro and in

teriza por dos factores, que vienen a determinar la especial responsabilidad que incumbe al Tribunal de Justicia en esta materia: de un lado, la inexistencia, en el